NYSE:GE
NYSE:GEAerospace & Defense

Should Delta’s Boeing 787 GEnx Engine Deal Reshape Earnings Expectations for General Electric (GE) Investors?

In the past week, GE Aerospace announced that Delta Air Lines chose its GEnx engines, spare engines, and long-term services to power 30 firm Boeing 787-10 orders, with options for 30 additional aircraft. This win further entrenches the GEnx family, which has accumulated more than 70 million flight hours and already equips about two-thirds of the global 787 fleet, reinforcing the engine’s installed base and long-term service potential. We’ll now examine how this expanded GEnx footprint with...
NYSE:AXP
NYSE:AXPConsumer Finance

Why American Express (AXP) Is Down 6.7% After Trump’s Proposed 10% Card Rate Cap And What's Next

In early January 2026, former President Donald Trump called for a one-year cap of 10% on credit card interest rates starting January 20, triggering political and regulatory scrutiny of issuers such as American Express and its peers across the banking and payments sector. Beyond the immediate policy uncertainty, the proposal raises deeper questions about how a forced reset of lending economics could reshape card rewards, credit availability, and the balance of power between traditional card...
NYSE:SDRL
NYSE:SDRLEnergy Services

How Investors May Respond To Seadrill (SDRL) After Citigroup’s Shift From Neutral To Sell

In the past few days, Citigroup downgraded offshore driller Seadrill from Neutral to Sell, signaling a more cautious stance on the company’s outlook and underlying risks. This shift adds to an already mixed analyst backdrop, highlighting how differing views on offshore demand, balance sheet strength, and legal exposures are shaping sentiment around Seadrill. We’ll now examine how Citigroup’s downgrade reshapes Seadrill’s investment narrative, particularly around future earnings resilience...
NasdaqGS:UPST
NasdaqGS:UPSTConsumer Finance

A Look At Upstart Holdings (UPST) Valuation After 2025 Growth, Profitability And New Credit Union Partnership

Upstart Holdings (UPST) is back in focus after reporting strong 2025 growth and profitability, even as rising credit risk, a softer labor market, and a new MyPoint Credit Union partnership complicate the stock’s setup. See our latest analysis for Upstart Holdings. Recent news, including strong 2025 results, the planned February earnings call, and the MyPoint Credit Union partnership, comes after a 1 year total shareholder return decline of 17.37% and a 3 year total shareholder return gain of...
NYSE:KR
NYSE:KRConsumer Retailing

Kroger (KR) Valuation Check As AI Partnership With Google Cloud Expands Across Digital Grocery Services

Kroger (KR) has put AI at the center of its digital push, expanding its work with Google Cloud to roll out Gemini Enterprise nationwide, with new shopping and meal planning assistants for online grocery customers. See our latest analysis for Kroger. Against this AI rollout and other recent updates, such as leadership changes across several retail divisions and new EVgo charging installations at Kroger locations, the shares trade at US$61.47 with a 90 day share price return of an 11.04%...
NYSE:JBL
NYSE:JBLElectronic

Is Jabil (JBL) Quietly Redefining GARP With Its AI-Linked, Cash-Generative Growth Model?

Jabil Inc. recently drew attention as analysts and commentators highlighted it as a Growth at a Reasonable Price stock, emphasizing its profitability, cash generation, and involvement across AI infrastructure, healthcare, and automotive end markets. While the company’s upcoming virtual-only annual stockholder meeting is routine, the more interesting angle is how Jabil’s combination of strong returns on capital, solid cash flow, and reasonable valuation has started to frame it as a balanced...
NYSE:CVX
NYSE:CVXOil and Gas

Is Chevron (CVX) Pricing Reflecting Its Recent Share Performance And Cash Flow Outlook

If you are wondering whether Chevron is fairly priced at its recent levels, this article walks through what the numbers say about the stock’s value. Chevron’s share price recently closed at US$163.87, with returns of 4.7% over the last 7 days, 9.3% over 30 days, 5.1% year to date, 9.3% over 1 year, and 3.0% over 3 years, while the 5 year return sits at 114.4%. These returns have kept Chevron firmly on many investors’ watchlists, as they try to gauge how much of the story is already reflected...
NasdaqGS:ROOT
NasdaqGS:ROOTInsurance

Assessing Root (ROOT) Valuation After Wells Fargo Turns More Cautious On Underwriting And Financial Health

Root (ROOT) is back in focus after a Wells Fargo analyst adopted a more cautious stance, pointing to concerns around the insurer’s financial position and a combined ratio of 102%, indicating underwriting losses. See our latest analysis for Root. The Wells Fargo call comes after a choppy stretch for Root, with a 1-day share price return of 6.71% decline taking the stock to US$74.26, a year to date share price return of 4.74%, and a 1-year total shareholder return of 12.44% decline. This...
NasdaqGS:ZBRA
NasdaqGS:ZBRAElectronic

Is Zebra Technologies (ZBRA) Pricing Reflect A Recovery After Last Year’s 33% Share Price Fall

If you are wondering whether Zebra Technologies is attractively priced right now, this article walks through what the current share price might be implying about the company’s value. The stock recently closed at US$261.44, with returns of 1.5% over the last 7 days, a 2.6% decline over the last 30 days, a 5.3% gain year to date and a 33.7% decline over the last year. These figures can change how investors view both its potential and its risks. Recent headlines have focused on Zebra...
NasdaqCM:RKLB
NasdaqCM:RKLBAerospace & Defense

Does Expanding U.S. Defense Work Reshape The Bull Case For Rocket Lab’s (RKLB) Space Strategy?

In recent months, Rocket Lab has secured its largest-ever US$816 million U.S. Space Development Agency contract, an additional U.S. Space Force award potentially approaching US$1 billion, and new missions with Canadian and Japanese space agencies, while preparing to showcase its progress at BofA’s 2026 Defense Outlook and Commercial Aerospace Forum. These expanding government partnerships highlight how Rocket Lab’s space systems and defense-focused technologies are becoming central to its...
NYSE:MMM
NYSE:MMMIndustrials

3M (MMM) Valuation Reassessed After PFAS Class-Action Lawsuit Survives Dismissal Attempt

A Montana federal judge’s refusal to dismiss a PFAS class-action lawsuit tied to firefighter turnout gear keeps 3M (MMM) firmly in the legal spotlight, with investors reassessing ongoing liability and reputation risk. See our latest analysis for 3M. The lawsuit setback arrives after a period of steadier trading for 3M, with the share price at $169.42 and a 90 day share price return of 10.39%, alongside a 1 year total shareholder return of 25.81% and 3 year total shareholder return of 78.94%...
NYSE:TSM
NYSE:TSMSemiconductor

Is It Too Late To Consider Taiwan Semiconductor Manufacturing (NYSE:TSM) After Its Strong Share Price Run

If you are wondering whether Taiwan Semiconductor Manufacturing at US$331.21 is still reasonably priced after a strong run, you are not alone. The stock has posted returns of 1.2% over the last 7 days, 13.4% over the last 30 days, 3.6% year to date, 66.1% over the last year and a very large 3 year return of 286.0%, with a 5 year return of 169.3%. These moves have come as investors continue to focus on Taiwan Semiconductor Manufacturing's role in the global chip supply chain and broader...
NYSE:SLG
NYSE:SLGOffice REITs

A Look At SL Green (SLG) Valuation After Rockpoint Partnership For 100 Park Avenue

SL Green Realty (SLG) has agreed to sell a 49% interest in its 100 Park Avenue office tower to Rockpoint, valuing the Midtown Manhattan property at US$425.0 million and creating a new joint venture. See our latest analysis for SL Green Realty. That joint venture news comes after a mixed period for investors, with a 30 day share price return of 9.23% but a 1 year total shareholder return decline of 19.06%. Recent momentum has picked up even as longer term performance remains weak. If this kind...
NasdaqGS:GLXY
NasdaqGS:GLXYCapital Markets

A Look At Galaxy Digital (NasdaqGS:GLXY) Valuation As U.S. Digital Asset Rules Move Toward Greater Clarity

Senate committees preparing to vote on new U.S. digital asset market structure rules have put regulatory clarity in focus for crypto-exposed stocks, including Galaxy Digital (GLXY), especially around institutional trading and custody. See our latest analysis for Galaxy Digital. Galaxy Digital’s recent 5.22% 1 day share price return to $26.82 comes after a tougher 90 day period with a 36.02% share price decline. The 1 year and 3 year total shareholder returns of 45.76% and over 7x respectively...
NasdaqGM:HROW
NasdaqGM:HROWPharmaceuticals

Is Harrow's (HROW) Softer 2025 Outlook Exposing a Fragile Revenue Mix Strategy?

In the past few days, Harrow signaled that 2025 revenue could land around US$265 million, falling short of its earlier US$270–US$280 million guidance range, as strength in Iheezo and Vevye is offset by pressure in specialty and compounded segments and one-time factors. This tension between robust growth in newer ophthalmic products and emerging headwinds in legacy segments raises fresh questions about how balanced Harrow’s revenue mix really is. Next, we’ll examine how concerns over a...
NasdaqGS:ISRG
NasdaqGS:ISRGMedical Equipment

A Look At Intuitive Surgical (ISRG) Valuation As AI Surgery Expectations Build Ahead Of Earnings

Trending interest in Intuitive Surgical (ISRG) centers on expectations that AI-enabled diagnostics and software revenue could reshape margins, with investors closely watching procedure volumes, recurring sales, and the upcoming January 22 earnings report. See our latest analysis for Intuitive Surgical. Recent trading has been choppy, with a 7 day share price return of 5.23% and a 1 day move lower. However, the 90 day share price return of 28.97% and 3 year total shareholder return of 114.66%...
NasdaqGS:EXEL
NasdaqGS:EXELBiotechs

Does Exelixis’ 2026 Revenue Guidance and Zanzalintinib Push Change The Bull Case For EXEL?

Exelixis recently released preliminary 2025 results, projecting total revenues of about US$2.32 billion and net product revenues of about US$2.12 billion, while guiding 2026 total revenues to US$2.53–2.63 billion and net product revenues to US$2.33–2.43 billion, alongside updates on its oncology pipeline and business. At the same time, Exelixis moved to expand beyond cabozantinib by advancing zanzalintinib toward a potential first commercial indication and launching a new colorectal cancer...
NYSE:VSCO
NYSE:VSCOSpecialty Retail

Victoria's Secret (VSCO) Is Up 7.4% After Earnings Beat And Analyst Upgrades Has The Bull Case Changed?

In early 2026, Victoria’s Secret drew heightened attention as analysts issued a wave of positive ratings following stronger-than-expected earnings and an upbeat outlook. This combination of renewed analyst confidence and improving company performance has sharpened focus on how sustainably Victoria’s Secret can execute its brand and operational transformation. With analysts turning more optimistic after the earnings surprise, we’ll now explore how this shift interacts with Victoria’s...
NasdaqGS:TSLA
NasdaqGS:TSLAAuto

Electric Vehicles Today - Design Drives Consumer Choices in Modern Vehicle Purchases

Recent research from Escalent reveals that while the electric vehicle (EV) industry has traditionally prioritized specifications like range and charging performance, consumer preference for design is a more significant motivator for battery electric vehicle (BEV) purchases. The study highlights that both interior and exterior vehicle design now overshadow traditional specs as primary reasons for choosing a BEV, with 71% of buyers prioritizing design in their decision-making process. Findings...
NasdaqGS:BNTX
NasdaqGS:BNTXBiotechs

A Look At BioNTech (BNTX) Valuation After Expanded Oncology Pipeline Update

BioNTech (NasdaqGS:BNTX) has laid out an expanded oncology plan for 2026, centered on a broader late-stage pipeline, additional combination studies with large partners, and more Phase 3 trial initiations and data readouts. See our latest analysis for BioNTech. The oncology update lands after a strong near term run, with a 1 day share price return of 4.90% and 30 day share price return of 13.06%. However, the 1 year total shareholder return of a 4.66% decline and 3 year total shareholder...
NYSE:COF
NYSE:COFConsumer Finance

Capital One Financial (COF) Is Down 10.3% After Trump Proposes 10% Credit Card Rate Cap

Earlier in January 2026, President Donald Trump called for a one-year cap on US credit card interest rates at 10%, a move that could materially reshape economics for major card issuers such as Capital One Financial by limiting interest income and potentially tightening lending standards. While framed as a way to save consumers billions of dollars in interest, the proposed cap could reduce access to traditional credit cards, push more borrowers toward alternatives such as 0% buy now, pay...
NYSE:CSL
NYSE:CSLBuilding

A Look At Carlisle Companies (CSL) Valuation After Recent Share Price Strength Rebuilds Longer Term Momentum

Carlisle Companies (CSL) has been drawing attention after recent share price moves, with the stock last closing at $356.42. Investors are weighing this level against the company’s latest financial profile and multi year return record. See our latest analysis for Carlisle Companies. The recent share price strength, including a 6.1% 7 day share price return and an 8.5% year to date share price return, contrasts with a 5.6% decline in 1 year total shareholder return. However, the 5 year total...
NYSE:UNM
NYSE:UNMInsurance

Is Unum Group (UNM) Still Attractive After Its Strong Multi‑Year Share Price Run?

If you are wondering whether Unum Group stock still offers value after its recent run, this article walks through what the current price might be implying. The share price recently closed at US$79.33, with returns of 0.9% over 7 days, 2.9% over 30 days, 2.7% year to date, 11.2% over 1 year and a very large gain over 5 years. Recent commentary around Unum Group has focused on how investors are reassessing insurers in general and what that could mean for pricing power and balance sheet...
NasdaqGS:LRCX
NasdaqGS:LRCXSemiconductor

Does Stronger AI-Focused Wafer-Fab Demand Recast the Bull Case For Lam Research (LRCX)?

In recent months, Lam Research reported stronger-than-expected quarterly results and guidance, while analysts highlighted its leading role in supplying equipment for advanced, AI-driven semiconductor manufacturing. A key theme emerging from the latest commentary is growing confidence that Lam’s exposure to memory and wafer-fab equipment demand could keep it central to the next phase of chip-industry investment. We’ll now examine how this stronger earnings backdrop and upbeat analyst...